
Our Blog
PANTHERx Closes 2019 with Another Consecutive #1 Patient Satisfaction Victory
February 28, 2020
PANTHERx Rare Pharmacy is proud to have again earned the #1 ranking in the quarterly patient satisfaction survey conducted by Zitter Health Insights, an independent...
Consistent Rise in Orphan Drug Approvals Brings Doses of Hope to the Rare Disease Community
January 8, 2020
The end of the decade brought with it an exciting and critical trend for people living with rare diseases. Over the last eight years, the...
PANTHERx Rare Pharmacy Issues RFI for a State-of-the-Art Pharmacy Management System
September 6, 2019
September 6, 2019 – Pittsburgh, PA PANTHERx Rare Pharmacy has issued a Request for Information (RFI) for a Pharmacy Management System (PMS) that...
PANTHERx Rare Pharmacy Recognized in the top 5% of the Inc. 5000 List of Fastest-Growing Companies in America for the 4th Consecutive Year
August 14, 2019
PANTHERx Rare Pharmacy announces that it has, for a 4th time, been named to the Inc. 5000 list, celebrating the fastest-growing private companies in America....
PANTHERx Serves on Rare Disease Advisory Panel to Create Quality Standards for Rare Disease Pharmacy Designation
July 8, 2019
Click here to read the full press release. As the medical community has learned more about rare diseases and the complex medications and models...
PANTHERx® Specialty Pharmacy Selected as 2019 Specialty Pharmacy Patient Choice Award Finalist
April 30, 2019
We are excited to announce that PANTHERx Specialty Pharmacy has been selected as a finalist in the category of Retail/Independent/Hospital and Health System Specialty Pharmacies...
Cardinal Health Specialty Solutions Strengthens Cell and Gene Therapy Offering with PANTHERx Specialty Pharmacy Collaboration
April 26, 2019
The Press Release that follows was published by Cardinal Health to formally announce the collaboration between PANTHERx Specialty Pharmacy and Cardinal Health. To read the...
PANTHERx®’s Leaders Present An American Journal of Managed Care® (AJMC) Webinar: The Clinical and Managed Care Implications of X-Linked Hypophosphatemia
November 19, 2018
PANTHERx® Specialty Pharmacy’s Chairman & CEO, Dr. Gordon J. Vanscoy, and PANTHERx®’s Manager of Clinical Programs, Dr. Christa Eans, will lead a Live CE Webinar...
PANTHERx® Specialty Pharmacy and RxCrossroads™ by McKesson Collaborate to Simplify the Channel for Precision Medicine Therapies
November 2, 2018
PANTHERx® Specialty Pharmacy, The Rare Disease Specialty Pharmacy®, and RxCrossroads™ by McKesson, the leading commercial solutions partner for life sciences companies, announced their collaborative program...
PANTHERx® Supports NASP Launch of Inaugural Student Pharmacist Chapter Program
July 19, 2018
The National Association of Specialty Pharmacy (NASP) recently announced the launch of their new Student Association of Specialty Pharmacy (SASP) via a segment on the...
